Non-Hodgkin lymphoma (NHL) is a subtype of blood cancer that starts in the lymphatic system. With early diagnosis and appropriate treatment, many forms of NHL are manageable and even curable. India has emerged as a leading destination for effective and affordable treatment of non-Hodgkin lymphoma, attracting patients from across Europe, Africa, the Middle East, and Southeast Asia.
The cost of non-Hodgkin lymphoma treatment in India typically ranges from ₹3,00,000 to ₹25,00,000 (approximately $3,600 to $30,000), depending on the type and stage of the disease, treatment methods used, and hospital facilities. This is significantly lower than treatment costs in Western countries, often offering savings of up to 80% while maintaining global standards of care.
Non-Hodgkin lymphoma (NHL) is a type of blood cancer that originates in the lymphatic system, a crucial component of the body's immune defense. It occurs when WBCs called lymphocytes grow abnormally and form tumors throughout the body. Unlike Hodgkin lymphoma, NHL does not involve the presence of Reed-Sternberg cells, a specific type of abnormal cell found only in Hodgkin lymphoma.
There are over sixty subtypes of Non-Hodgkin lymphoma, which are classified into two main categories:
Some types of NHL are slow-growing (indolent), while others are fast-growing (aggressive). Common types include diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. The course of the disease and treatment approach vary depending on the type and stage of NHL.
Non-Hodgkin lymphoma symptoms often resemble those of common infections, which can delay diagnosis if not correctly evaluated. Swollen lymph nodes cause some symptoms, while others are related to how the disease affects organs such as the spleen, liver, or bone marrow.
Common symptoms include:
If these symptoms persist for more than a few weeks or are unexplained by other conditions, a thorough medical evaluation is strongly recommended.
India offers world-class treatment for non-Hodgkin's lymphoma, combining advanced technologies, experienced oncologists, and globally recognized treatment protocols. International patients benefit from world-class oncology hospitals equipped to handle chemotherapy, radiation therapy, and stem cell transplantation.
The treatment approach for non-Hodgkin's lymphoma in India depends on several factors, such as the specific subtype, stage, and aggressiveness of the disease, as well as the patient's age, overall health, and medical history. The goal of the treatment is to eliminate cancer cells, prevent relapse, and improve long-term survival.
Commonly used treatment modalities in India include:
The treatment protocol for non-Hodgkin's lymphoma follows a structured sequence aimed at achieving remission, preventing relapse, and maintaining quality of life. While protocols vary slightly depending on the subtype and severity, most patients go through a combination of induction, consolidation, and maintenance phases.
Typical treatment protocol includes:
This structured, evidence-based approach ensures optimal outcomes while minimizing unnecessary side effects. Top Indian oncologists, such as Dr. Rahul Bhargava, follow NCCN and ESMO guidelines, ensuring consistency with global standards of care.
India is globally recognized for providing high-quality cancer care at a fraction of the cost charged in countries such as the United States, the UK, or the UAE. Non-Hodgkin lymphoma (NHL) treatment in India is not only affordable but also follows international protocols and utilizes the latest medical technologies.
Most patients with non-Hodgkin's lymphoma can expect an overall treatment cost between ₹6,00,000 and ₹30,00,000 (approximately $7,200 to $36,000) depending on the treatment path and medical complexity.
This cost includes high-quality medical services, internationally trained doctors, and access to advanced treatments, making India a top choice for international cancer care.
Below is a general cost breakdown for various components of NHL treatment in India:
One of the most compelling reasons patients travel to India for NHL treatment is the remarkable cost savings. Here is a comparative table showing the average cost range for complete NHL treatment across different countries:
Country |
Chemotherapy + Targeted Therapy |
Stem Cell Transplant (Autologous) |
CAR T-Cell Therapy |
India |
$7,000 – $15,000 |
$15,000 – $25,000 |
$40,000 – $60,000 |
USA |
$60,000 – $120,000 |
$100,000 – $200,000 |
$400,000 – $500,000 |
UK |
$45,000 – $90,000 |
$80,000 – $160,000 |
Not widely available privately |
UAE |
$35,000 – $70,000 |
$60,000 – $120,000 |
$250,000 – $400,000 |
Thailand |
$20,000 – $30,000 |
$35,000 – $50,000 |
Not routinely offered |
South Africa |
$25,000 – $45,000 |
$50,000 – $70,000 |
Limited availability |
International patients visiting India can save up to 80–90% on total treatment costs, even when factoring in travel, accommodation, and post-treatment care. More importantly, they receive world-class care with access to advanced therapies, such as immunotherapy and stem cell transplants.
The total cost of treating non-Hodgkin lymphoma (NHL) in India varies widely based on several medical, logistical, and personal factors. Understanding these factors helps patients and caregivers plan finances, select the right hospital, and prepare for the duration of treatment.
India is a leading destination for international cancer patients seeking affordable, evidence-based, and technologically advanced care. When it comes to treating Non-Hodgkin lymphoma, the country offers several unique advantages:
Fatima D., Kenya
"When I was diagnosed with Burkitt Lymphoma, my family and I were devastated. The treatment options in Nairobi were limited and extremely expensive. We found Fortis Hospital in Gurgaon and connected with Dr. Rahul Bhargava through a patient referral. The team was incredibly supportive from the beginning, helping with visas, airport pickup, and accommodations. I underwent six cycles of R-CHOP chemotherapy followed by a short course of radiation. Today, I'm cancer-free and back to living my life. The care I received in India was not just affordable, but it was world-class."
Reza M., Iran
"As a 43-year-old engineer, my life took a turn when I was diagnosed with stage III non-Hodgkin lymphoma. I couldn't afford treatment in Europe and feared losing time. A friend suggested India. I researched and chose a leading hospital in Delhi. The doctors were transparent, knowledgeable, and kind. My chemotherapy cycles went smoothly, and the nurses took great care of me. Language wasn't a problem as they arranged a translator. I'm now in remission and forever grateful for the second chance India gave me."
Yes, many types of non-Hodgkin lymphoma are curable, especially when detected early. Aggressive lymphomas often respond well to chemotherapy and immunotherapy, and some patients achieve long-term remission or complete cure.
The success rate for non-Hodgkin's lymphoma treatment in India ranges from 60% to 90%, depending on the type of lymphoma, stage at diagnosis, and overall patient health. Indolent forms may have a chronic course but are manageable for many years with proper care.
Most chemotherapy regimens last 3 to 6 months. In cases requiring a stem cell transplant, treatment duration may extend to 6–9 months, including preparation and recovery time. Regular follow-ups are essential after treatment.
Doctors usually recommend staying in India for 2–4 weeks post-treatment to monitor recovery and manage any side effects. In the case of transplants, patients may need to stay longer for immune recovery.
Yes, many hospitals treating non-Hodgkin's lymphoma in India are NABH (National Accreditation Board for Hospitals) and JCI (Joint Commission International) accredited, ensuring global standards in care.
Absolutely. Indian hospitals provide teleconsultation services for post-treatment follow-up, ensuring continuity of care after you return home.
Yes, cancer hospitals in India welcome caregivers and even provide accommodation and meal support for them within or near the hospital premises.
Most hospitals offer multilingual support, including interpreters for Arabic, French, Swahili, Russian, and other languages, to help international patients communicate effectively with healthcare professionals.
Some international insurance providers do cover treatment abroad. Patients should consult with their insurance companies and the hospital's international patient team to obtain pre-approval and coordinate billing.